ZOSTAVAX, powder and solvent for injectable suspension in a pre-filled syringe. vaccine zona (live attenuated) bottle
Active ingredients: VIRUS VARICELLE-ZONA SOUCHE OKA/MERCK (VIVANT, ATTÉNUÉ)
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for injectable suspensionbottleintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZOSTAVAX, poudre et solvant pour suspension injectable en seringue préremplie. Vaccin zona (vivant atténué)
- Pharmaceutical form
- poudre et solvant pour suspension injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre avec 2 aiguille(s)
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 13 Aug 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60956323CIP73759300CIP133400937593007Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VIRUS VARICELLE-ZONA SOUCHE OKA/MERCK (VIVANT, ATTÉNUÉ)poudre | pas moins de 19 400 UFP · une dose de 0,65 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.